Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Menveo Ad Should Not List CDC Recommendations Because It Does Not Meet Them, FDA Says

This article was originally published in The Pink Sheet Daily

Executive Summary

The approved use of Novartis' meningococcal disease vaccine does not match up with CDC recommendations, FDA says in a letter to the company.

You may also be interested in...



Forget Twitter – Telephone Script Also Snags FDA Citation

Office of Prescription Drug Promotion objects to Concordia’s telephone script for attention deficit hyperactivity disorder drug Kapvay.

Drug Ads Should Take A Long View, DDMAC Says In Citing Time-To-Onset Claims

FDA sends notice of violation letters to Dow Pharmaceutical Sciences (Valeant) and Novartis for stretching a point in promotional materials for Acanya Gel and Focalin XR, respectively.

Drug Ads Should Take A Long View, DDMAC Says In Citing Time-To-Onset Claims

FDA sends notice of violation letters to Dow Pharmaceutical Sciences (Valeant) and Novartis for stretching a point in promotional materials for Acanya Gel and Focalin XR, respectively.

Related Content

Topics

UsernamePublicRestriction

Register

LL005491

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel